Use of Neuraminidase Inhibitors for Rapid Containment of Influenza: A Systematic Review and Meta-Analysis of Individual and Household Transmission Studies

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

(2013) Alicia M Fry et al.   LANCET INFECTIOUS DISEASES

Case Characteristics and Use of Oseltamivir in Children and Household Contacts

(2012) Aurelia A. Fallo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009

(2010) Edward Goldstein et al.   BMC INFECTIOUS DISEASES

Serial Intervals and the Temporal Distribution of Secondary Infections within Households of 2009 Pandemic Influenza A (H1N1): Implications for Influenza Control Recommendations

(2010) C. A. Donnelly et al.   CLINICAL INFECTIOUS DISEASES

Effects of Oseltamivir Treatment on Duration of Clinical Illness and Viral Shedding and Household Transmission of Influenza Virus

(2010) Sophia Ng et al.   CLINICAL INFECTIOUS DISEASES

Oseltamivir, zanamivir and amantadine in the prevention of influenza: A systematic review

(2010) Rachel J. Jackson et al.   JOURNAL OF INFECTION

Oseltamivir Ring Prophylaxis for Containment of 2009 H1N1 Influenza Outbreaks

(2010) Vernon J. Lee et al.   NEW ENGLAND JOURNAL OF MEDICINE

Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies

(2008) Fabrice Carrat et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Modeling targeted layered containment of an influenza pandemic in the United States

(2008) M. E. Halloran et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA